# Phase II Roadmap

## Purpose

Phase II should turn the Phase I prototype into a secure pilot-ready platform for real provider workflows and eventual commercialization.

Phase I proves feasibility. Phase II should fund production hardening, real-world pilots, security and compliance work, deeper interoperability, and business development.

## Phase II Product Goal

ClearPath should become a patient-controlled communication layer for interoffice and interdisciplinary health information exchange.

Phase II should support:

- Real provider organizations
- Real patient consent workflows
- Secure handling of PHI where legally and operationally appropriate
- Multi-office request, approval, response, and review workflows
- Auditable consent packages
- Early interoperability translators and export formats

## Major Workstreams

### 1. Production Platform Hardening

Objectives:

- Move from prototype architecture to production-ready architecture.
- Harden authentication, authorization, logging, and data access controls.
- Support tenant separation for multiple practices or organizations.

Likely deliverables:

- Production deployment architecture
- Role-based access controls
- Secure audit logging
- Environment separation
- Error monitoring and incident workflow
- Data retention and deletion policies

### 2. Compliance And Security Implementation

Objectives:

- Prepare ClearPath to handle real PHI in pilot environments.
- Convert Phase I legal/security recommendations into operational safeguards.

Likely deliverables:

- HIPAA security risk analysis
- HIPAA privacy and security policies
- Business associate agreement templates
- Third-party penetration test
- Vulnerability remediation
- Security training materials
- Incident response plan
- Vendor risk documentation

### 3. Record Request Network Workflow

Objectives:

- Support both requesting offices and responding offices.
- Move beyond patient-held data into interoffice request and response.

Likely deliverables:

- Provider request inbox and outbox
- Source office response workflow
- Secure document upload and attachment review
- Request due dates, urgency, status, and reminders
- Patient-facing history of requests and releases
- Office-to-office message thread tied to patient approval

### 4. Interoperability Translators

Objectives:

- Keep JSON as the internal ClearPath hub language.
- Add useful translation paths for common healthcare exchange workflows.

Likely deliverables:

- FHIR Bundle export prototype
- C-CDA or document package research/prototype
- CSV and PDF refinements
- Reviewed-import packages for early practice systems
- Vendor-specific integration research for priority systems
- Mapping documentation and test fixtures

### 5. Pilot Deployment

Objectives:

- Validate ClearPath in real workflow settings.
- Collect evidence needed for commercialization and future grants.

Likely deliverables:

- Pilot site selection
- Pilot agreements
- Training materials
- User support process
- Workflow metrics
- User satisfaction findings
- Safety and privacy monitoring
- Lessons learned report

### 6. Commercialization

Objectives:

- Define the business model and path to sustainability.
- Build evidence for customers, partners, and future funders.

Likely deliverables:

- Pricing model
- Customer segment analysis
- Buyer and user personas
- Competitive analysis
- Sales materials
- Partnership plan
- Phase III/non-grant funding strategy

## Phase II Milestone Sequence

### Months 1-3: Foundation

- Hire expanded technical and compliance support.
- Complete production architecture plan.
- Begin HIPAA security risk analysis.
- Select pilot candidates.
- Finalize Phase II product requirements.

### Months 4-8: Build And Harden

- Build multi-office request and response workflows.
- Add stronger access controls and audit logs.
- Create secure package/document exchange.
- Prepare initial FHIR/PDF/CSV translation outputs.
- Begin security remediation from architecture review.

### Months 9-12: Security And Pilot Preparation

- Complete penetration test.
- Remediate high-priority security findings.
- Finalize pilot policies and BAAs.
- Train pilot users.
- Run synthetic-data pilot rehearsals.

### Months 13-18: Pilot Execution

- Launch controlled pilot with approved sites.
- Monitor request volume, approval rates, completion time, and user feedback.
- Collect clinical workflow and administrative burden findings.
- Continue product iteration.

### Months 19-24: Commercialization And Scale Plan

- Summarize pilot outcomes.
- Finalize commercialization strategy.
- Prepare customer-facing materials.
- Define Phase III funding, sales, or partnership path.
- Prepare final Phase II reporting.

## Phase II Success Criteria

ClearPath should be ready for broader commercialization when:

- Providers can request and review records across offices.
- Patients can approve, deny, limit, and revoke access.
- Real PHI can be handled under documented security and compliance controls.
- The platform has passed third-party security testing.
- Pilot users confirm the workflow saves time or improves record access.
- The business model and buyer path are credible.
